Page 121 - Human Bile Acid Metabolism: a Postprandial Perspective

21. Kohli R, Bradley D, Setchell KD, Eagon JC, Abumrad N, Klein S. Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding in- creases circulating bile acids. J Clin Endocrinol Metab 2013;98(April):708–12.
22. LaRusso NF, Hoffman NE, Korman MG, Hofmann AF, Cowen AE. Determinants of fasting and postprandial serum bile acid levels in healthy man. Am J Dig Dis 1978; 23(5):385–91.
23. Dutia R, Embrey M, O’Brien CS, Haeusler RA, Agénor KK, Homel P, et al. Temporal changes in bile acid levels and 12α-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes. Int J Obes (Lond) 2015;39(April):806–13.
24. Sachdev S, Wang Q, Billington C, Connett J, Ahmed L, Inabnet W, et al. FGF 19 and bile acids increase following Roux-en-Y gastric bypass but not after medical man- agement in patients with type 2 diabetes. Obes Surg 2016;26(5):957–65.
25. De Giorgi S, Campos V, Egli L, Toepel U, Carrel G, Cariou B, et al. Long-term effects of Roux-en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: a cross-sectional pilot study. Clin Nutr 2015;34(5):911–7.
26. van Nierop FS, Kulik W, Endert E, Schaap FG, Olde Damink SW, Romijn JA, et al. Ef- fects of acute dietary weight loss on postprandial plasma bile acid responses in obese insulin resistant subjects. Clin Nutr 2016;13:1–6.
27. Pellicoro A, van den Heuvel FAJ, Geuken M, Moshage H, Jansen PLM, Faber KN. Human and rat bile acid-CoA:amino acid N-acyltransferase are liver-specific peroxisomal enzymes: implications for intracellular bile salt transport. Hepatology 2007;45(2):340–8.
28. Gurantz D, Schteingart CD, Hagey LR, Steinbach JH, Grotmol T, Hofmann AF. Hypercholeresis induced by unconjugated bile acid infusion correlates with recov- ery in bile of unconjugated bile acids. Hepatology 1991;13(3):540–50.
29. Hamilton JP, Xie G, Raufman J-P, Hogan S, Griffin TL, Packard CA, et al. Human cecal bile acids:
concentration and spectrum. Am J Physiol Gastrointest Liver Physiol 2007;293(1):G256–63. 6
30. Eggink HM, van Nierop FS, Schooneman MG, Boelen A, Kalsbeek A, Koehorst M, et al. Transhepatic bile acid kinetics in pigs and humans. Clin Nutr 2017;37(4):1–9.
31. Docherty NG, Le Roux CW. Physiological adaptations following Roux-en-Y gastric bypass and the identification of targets for bariatric mimetic pharmacotherapy. Curr Opin Pharmacol 2015;25(18):23– 9.
32. Pournaras DJ, Glicksman C, Vincent RP, Kuganolipava S, Alaghband-Zadeh J, Mahon D, et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 2012;153(August):1–7.
33. Kaválková P, Mráz M, Trachta P, Kloučková J, Cinkajzlová A, Lacinová Z, et al. Endo- crine effects of duodenal–jejunal exclusion in obese patients with type 2 diabetes mellitus. J Endocrinol 2016;231(1):11–22.
34. Zhang F, Yu L, Lin X, Cheng P, He L, Li X, et al. Minireview: roles of fibroblast growth factors 19 and 21 in metabolic regulation and chronic diseases. Mol Endocrinol 2015;29(10):1400–13.
35. Al-khaifi A, Rudling M, Angelin B. An FXR agonist reduces bile acid synthesis inde- pendently of increases in FGF19 in healthy volunteers. Gastroenterology 2018 Oct; 155(4):1012–6.
Duodenal-jejunal bypass liner
119